Pressmeddelande04.09.2025 klo 19.10Eevia Health Abp: Utfall av nyttjandet av Bolagets teckningsoptioner av serie TO1
Pressmeddelande04.09.2025 klo 19.08Eevia Health Abp: Tingsrätten i Södra-Österbotten beslutat att försätta Eevia i konkurs
Pressmeddelande22.08.2025 klo 11.43Notice of the Annual General Meeting of Shareholders 2025 in Eevia Health Plc
Regulatoriskt pressmeddelande22.08.2025 klo 11.30Eevia Health: Eevia Board Recommends Voluntary Liquidation
Regulatoriskt pressmeddelande21.08.2025 klo 15.05Update: Eevia Health Reverses Eye-Health IP Transaction
Regulatoriskt pressmeddelande13.08.2025 klo 11.00Eevia Health: UPDATE: Eevia Warns of Continued Strained Liquidity, Delayed Audit and Write Downs
Pressmeddelande13.06.2025 klo 09.30Eevia Health Secures c. EUR 50,000 in New Sales Orders Across Key Markets
Pressmeddelande13.06.2025 klo 09.00Eevia Health Receives HALAL Certification, Unlocking New Market Opportunities
Regulatoriskt pressmeddelande12.06.2025 klo 14.57Eevia Health Relocates Production to Norwegian Nutraceutical Biotechnology Hub to Drive Innovation, Avoid Investments and Cut Costs
Regulatoriskt pressmeddelande12.06.2025 klo 14.49Eevia Health Warns of Strained Liquidity and Delayed Audit
Regulatoriskt pressmeddelande23.05.2025 klo 13.40UPDATE: Eevia Health Enters Five-Year Supply Agreement
Pressmeddelande14.05.2025 klo 16.20Eevia Health: Eevia LAUNCHES A HIGH-STRENGTH ORGANIC ARONIA EXTRACT AT VITAFOODS 2025
Pressmeddelande09.05.2025 klo 08.59Eevia Health: Eevia Enters Strategic North American Partnership with a KSEK 765 First Sales Order